Mild cognitive impairment -- marked by a loss in short-term memory in particular -- may be a stronger predictor of Alzheimer’s disease than so-called “biomarkers,” which include things such as changes in brain volume or levels of certain proteins in cerebrospinal fluid, a new study suggests. Spanish researchers looked at 116 people with mild cognitive impairment (MCI) who developed Alzheimer’s disease within two years, 204 patients with the condition who didn’t develop Alzheimer’s and 197 people with no cognitive problems.
